The agent retrieved the homepage, fund page, and FAQ to gather basic product information, fees, and eligibility, but encountered contradictory regulatory claims and unfinished UI elements that prevented a complete picture. The site is partially agent-ready: it surfaces key facts (minimum, fees, strategy) directly in fetchable pages, but lacks structural clarity on regulation, risk disclosures, and team details.

• ›Regulatory contradiction is site-native and unresolved: FAQ claims AFM supervision; fund page claims the investment falls outside AFM supervision. This is the most critical gap for a financial product and appears to reflect genuine ambiguity or incomplete content on the site itself.
• ›Fees and minimums are clearly stated on the fund and FAQ pages (€100k minimum, 1.5% management, 15% performance, 0.5% exit fee), making pricing transparent and agent-discoverable.
• ›Performance claims (21.49% average yearly, 8.51 Sharpe ratio) on the homepage lack methodology, period, or audit trail; the agent correctly flagged the Sharpe ratio as implausibly high and noted it requires independent verification—a case where the site published claims without supporting evidence.
• ›Placeholder text ('Calendly integration will be embedded here') and broken links ('Start Investing' → '#') indicate the site is incomplete; this limited the agent's ability to complete the task without external resources.
• ›The agent did not fetch /team, /contact, or the investor portal, and did not open linked documents (Information Memorandum, factsheet, DocSend); team information was thus unavailable, but the agent correctly acknowledged this limitation in its response.